About Vishal

Vishal S. Vaidya, Ph.D. is an Assistant Professor of Medicine and Environmental Health at Harvard Medical School and Harvard School of Public Health. He is also an Associate Faculty at the Harvard University’s Center for Environment. Vishal directs the laboratory of kidney toxicology and regeneration in the renal division of Brigham and Women's Hospital with a research emphasis on discovery and evaluation of biomarkers and biosensors for early detection of kidney injury and investigating the molecular mechanisms of kidney tissue repair.

Molecular Signals to Understand Exposure Biology (MSEB)

BWH and HMS

Molecular Signals to Understand Exposure Biology (MSEB)

	Date	Title	Lecturer	Presentation
1	1/26/12	Introduction	Nader Rifai, Ph.D.	This is an introductary lecture on importance of biomarkers.
2	2/2/12	Genomics and Deep Sequencing Strategies for Biomarker Discovery	Peter Park, Ph.D.	Importance of next generations equencing technology for biomarker discovery.
3	2/9/12	Proteomic and Metabolomic Approaches toward Biomarker Identification	Clary B. Clish, Ph.D. Hanno Steen, Ph.D.	Principles and applications of metabolomics for biomarker discovery. Use of proteomics in biomarker discovery.
4	2/16/12	Molecular Signals to understand Lung Exposure Biology	David Christiani, M.D.	Lung exposure biology with respect to disease pathophysiology and biomarkers.
5	2/23/12	Molecular Signals to understand Brain Exposure Biology	Francisco Quintana, Ph.D.	Biomarkers and disease pathogenesis of multiple sclerosis.
6	3/1/12	Molecular Signals to understand Exposure Biology in Cancer	Marsha Moses, Ph.D.	An overview of novel non invasive cancer biomarkers.
7	3/8/12	Molecular Signals to understand Liver Exposure Biology	Shashi Ramaiah, DVM, Ph.D.	Need for biomarkers that outperform traditional biomarkers of liver injury.
8	3/22/12	Molecular Signals to understand Heart Exposure Biology	Jim Januzzi, M.D.	Recent advances in cardiovascular biomarkers.
9	3/29/12	Molecular Signals to understand Kidney Exposure Biology	Vishal S. Vaidya, Ph.D.	Overview and a case study for biomarkers for early detection of kidney injury.
10	4/5/12	Molecular Signals to understand Exposure Biology in Obstetric Medicine	Ananth Karumanchi, M.B.B.S.	Discovery, evaluation and clinical application of preeclampsia biomarker.
11	4/12/12	Molecular Signals to understand Exposure Biology in Infections	Lindsey Baden, M.D.	Potential challenges in developing biomarkers for infectious diseases such as HIV, invasive fungal infections, etc.
12	4/19/12	Micro and Nanoscale technologies to quantify biomarkers rapidly	David Wood, Ph.D.	An overview of principles of nano and micro scale technologies for biomarker discovery and quantitation.
13	4/28/12	Imaging biomarkers in disease states	Jeffery Yap, Ph.D.	Different imaging modalities that can be used as sensitive biomarkers for diagnosis, prognosis and interventions.
14	5/3/12	Clinical Study Design to Evaluate and Validate Molecular Signals	Sushrut Waikar, M.D., M.P.H.	How best to conduct clinical studies for biomarker evaluation and qualification.
15	5/10/12	Statistical Considerations in Biomarker Research	Rebecca Betensky, Ph.D.	Definitions as well as the advantages and disadvantages of most commonly used statistical approaches in biomarker research.